POLBF (Poolbeg Pharma) Tax Rate %: 0.68% (As of Dec. 2025)


What is Poolbeg Pharma Tax Rate %?

Poolbeg Pharma POLBF Tax Rate % is 0.68% as of Dec. 2025. The stock has 1 warning sign investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Poolbeg Pharma's Tax Expense for the six months ended in Dec. 2025 was $-0.03 Mil. Poolbeg Pharma's Pre-Tax Income for the six months ended in Dec. 2025 was $-4.74 Mil. Therefore, Poolbeg Pharma's Tax Rate % for the quarter that ended in Dec. 2025 was 0.68%.

Poolbeg Pharma Tax Rate % Related Terms

Poolbeg Pharma Tax Rate % Historical Data

* Premium members only.

The historical data trend for Poolbeg Pharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Tax Rate % Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
0.00 1.91 12.75 2.59 1.37

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Rate % Get a 7-Day Free Trial Premium Member Only 21.32 1.10 3.52 2.48 0.68

Poolbeg Pharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Poolbeg Pharma's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-0.106/-7.73
=1.37 %

Poolbeg Pharma's Tax Rate % for the quarter that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (Q: Dec. 2025 )/Pre-Tax Income (Q: Dec. 2025 )
=-0.032/-4.74
=0.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.68% mean?
Poolbeg Pharma (POLBF) has a Tax Rate % of 0.68% as of Dec. 2025.
Is Poolbeg Pharma's Tax Rate % too high?
Poolbeg Pharma's current Tax Rate % is 0.68%.
How does Poolbeg Pharma's Tax Rate % compare to VRTX and REGN?
Poolbeg Pharma's Tax Rate % of 0.68% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Poolbeg Pharma's current Tax Rate % is 0.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poolbeg Pharma stock overvalued right now?
Poolbeg Pharma (POLBF) has a current Tax Rate % of 0.68%. The current Tax Rate % is 0.68%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Poolbeg Pharma (POLBF), the current Tax Rate % is 0.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poolbeg Pharma Business Description

Other Exchanges POLB:UK7JN:Germany
Address 20 St. Andrew Street, The Clubhouse Holborn, London, GBR, EC4A 3AG
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.